Table 2.

Univariate Analysis and Multivariate Analysis for 28-Day Survival of Acute Myeloid Leukemia Patients

Variable	Category	Univariate Analysis			Multivariate Analysis
		Hazard Ratio	95% CI	P value	Hazard Ratio		95% CI	P value
Therapy	Chemotherapy + leukapheresis	1.140	0.396–3.283	0.809	–		–	–
	Chemotherapy	1
Age	≥60 years	2.513	0.805–7.851	0.113	5.541		1.031–29.781	0.046
	<60 years	1			1
BMI	≥25 kg/m2	3.292	1.180–9.183	0.023	3.465		0.934–12.959	0.063
	<25 kg/m2	1			1
Blast	≥90%	2.322	0.747–7.224	0.146	6.058		1.464–25.075	0.013
	<90%	1			1
Creatinine	≥1.4 mg/dL	2.516	0.925–6.844	0.071	5.749		1.792–18.442	0.003
	<1.4 md/dL	1			1
Gastrointestinal Leukostasis	Yes	1.567	0.562–4.370	0.391	–		–	–
	No	1
Tumor Lysis Syndrome	Yes	0.656	0.226–1.902	0.437	–		–	–
	No	1
Disseminated Intravascular Coagulation	Yes	2.005	0.738–5.444	0.172	6.541		1.822–23.490	0.004
	No	1			1
Chronic Comorbidities	Yes	0.439	0.141–1.369	0.156	–		–	–
	No	1